Fast and easy monitoring
of CIPN
The Mediracer® NCS is intended to measure sensory nerve conduction from peripheral nerves for objective assessment of chemotherapy-induced peripheral neuropathy. Compact sized device is extremely user friendly for frequent monitoring during the chemotherapy treatment.
Easy monitoring of
Chemotherapy-Induced
Peripheral Neuropathy
The diagnostic method is reliable and objective when detecting peripheral neuropathies. Examination will only take minutes for chemotherapy-induced peripheral neuropathy that afflicts large number of patients undergoing chemotherapy.
Mediracer® NCS is a certified class IIa medical device in Europe (CE), U.S. (FDA), Japan (PMDA), Korea (KFDA) and Australia (TGA).
Mediracer® NCS
Handheld Mediracer® NCS is reliable, fast and cost-efficient diagnostic tool for measuring sensory and motor nerve conduction. Mediracer® NCS requires only a short training to operate, and user-friendly analysis software makes the examination process straightforward. The handset is easy to use and the preconfigured disposable surface electrodes ensure easy and correct attachment.
Order Mediracer® NCS Brochure
Assessment solution for CIPN
Mediracer® NCS solution comprises of a handheld NCS device, disposal electrodes, sensory and/or motor cables, charger and analysis software for PC. Mediracer turnkey solution provides optional remote interpretation service by clinical neurophysiologist, or a platform for interpretation by a local doctor.
Phone
+358 45 899 2626
info@mediracer.com
Location
Kasarmintie 13, 90130 Oulu Finland